# Greenlight Vaporization vs Xpeeda Vaporesection

> **NCT04386941** · NA · COMPLETED · sponsor: **Thunder Bay Regional Health Research Institute** · enrollment: 97 (actual)

## Conditions studied

- Benign Prostatic Hyperplasia
- Lower Urinary Tract Symptoms

## Interventions

- **PROCEDURE:** Xpeeda Fibre Laser Vaporesection of the Prostate
- **PROCEDURE:** Greenlight XPS Vaporization of the Prostate

## Key facts

- **NCT ID:** NCT04386941
- **Lead sponsor:** Thunder Bay Regional Health Research Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-07-31
- **Primary completion:** 2022-07-10
- **Final completion:** 2024-07-31
- **Target enrollment:** 97 (ACTUAL)
- **Last updated:** 2025-04-10

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04386941

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04386941, "Greenlight Vaporization vs Xpeeda Vaporesection". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT04386941. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*